Results 11 to 20 of about 124,517 (353)

Recurrent pyogenic cholangitis

Clinical Case Reports, 2023
Key Clinical Message The incidence of hepatolithiasis is variable. Globalization has additionally altered disease dynamics globally. A multi‐disciplinary team approach is deemed necessary for the timely diagnosis, safe, affordable treatment, and good ...
Narendra Pandit, Durga Neupane
doaj   +3 more sources

AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma.

Hepatology, 2022
Pathogenesis of PSC. The current model of the pathogenesis of PSC involves four major themes on a background of underlying genetic and environmental risk factors.
C. Bowlus, L. Arrivé, A. Bergquist, M. Deneau, L. Forman, Sumera I. Ilyas, K. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, R. Shroff, J. Tabibian, D. Assis   +11 more
semanticscholar   +1 more source

Primary biliary cholangitis: Epidemiology, prognosis, and treatment

Hepatology Communications, 2023
Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the presence of antimitochondrial antibodies.
Juan Trivella, Binu V. John, C. Levy
semanticscholar   +1 more source

Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations

BMC Gastroenterology, 2023
Background Gallstone disease poses a significant health burden in the United States. Choledocholithiasis and cholangitis are common complications of gallstone disease for which data on current epidemiological trends are lacking.
Suqing Li, L. Guizzetti, Christopher Ma, A. Shaheen, E. Dixon, C. Ball, S. Wani, N. Forbes   +7 more
semanticscholar   +1 more source

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease

Hepatology, 2022
Cholestasis is associated with disease severity and worse outcome in COVID‐19. Cases of secondary sclerosing cholangitis (SSC) after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection have been described.
L. Hartl, Katharina Haslinger, Martin Angerer, G. Semmler, M. Schneeweiss-Gleixner, M. Jachs, B. Simbrunner, D. Bauer, E. Eigenbauer, R. Strassl, M. Breuer, O. Kimberger, D. Laxar, K. Lampichler, E. Halilbasic, A. Stättermayer, A. Ba-Ssalamah, M. Mandorfer, B. Scheiner, T. Reiberger, M. Trauner   +20 more
semanticscholar   +1 more source

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics

Biomedicines, 2022
Cholangiopathies encompass various biliary diseases affecting the biliary epithelium, resulting in cholestasis, inflammation, fibrosis, and ultimately liver cirrhosis.
Ji-won Park, Jung-Hee Kim, Sung-Eun Kim, J. Jung, M. Jang, S. Park, Myung‐Seok Lee, H. Kim, K. Suk, D. J. Kim   +9 more
semanticscholar   +1 more source

Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma [PDF]

, 2016
The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and specific biomarkers, as is the early diagnosis of cholangiocarcinoma (CC), a complication of PSC.
Alpini, Gianfranco, Alvaro, Domenico, Bernuzzi, Francesca, Bowlus, Christopher L, Carbone, Marco, Eric Gershwin, M, He, Xiao Song, Invernizzi, Pietro, Lleo, Ana, Locati, Massimo, Marabita, Francesco, Marzioni, Marco, Mirolo, Massimiliano, Muri Boberg, Kirsten, Piscaglia, Fabio, Rimassa, Lorenza, Torzilli, Guido, Yang, Guo Xiang   +17 more
core   +2 more sources

THE ROLE OF ENDOTHELIAL DYSFUNCTION IN THE PATHOGENESIS OF LIVER FAILURE IN OBSTRUCTIVE JAUNDICE OF BENIGN ORIGIN

Паёми Сино, 2022
Objective: To study the role of endothelial dysfunction in the pathogenesis of liver failure (LF) in obstructive jaundice of benign origin (OJBO). Methods: The study was based on the analysis of the results of a clinical examination of 68 patients ...
M.K. GULOV, K.R. RUZIBOYZODA, S.M. ABDULLOZODA, B.I. SAFAROV   +3 more
doaj   +1 more source

Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.

Journal of Hepatology, 2021
BACKGROUND&AIMS Primary sclerosing cholangitis (PSC) is characterized by chronic inflammation and progressive fibrosis of the biliary tree. The bile acid receptor TGR5 is found on biliary epithelial cells (BECs), where it promotes secretion ...
M. Reich, L. Spomer, C. Klindt, Katharina Fuchs, J. Stindt, K. Deutschmann, J. Höhne, E. Liaskou, J. Hov, T. Karlsen, U. Beuers, J. Verheij, Sofía Ferreira-González, G. Hirschfield, S. Forbes, C. Schramm, I. Esposito, D. Nierhoff, P. Fickert, C. Fuchs, M. Trauner, María García-Beccaria, G. Gabernet, S. Nahnsen, Jan-Philipp Mallm, M. Vogel, K. Schoonjans, Tobias Lautwein, K. Köhrer, D. Häussinger, T. Luedde, M. Heikenwalder, V. Keitel   +32 more
semanticscholar   +1 more source

Difficulties in Diagnosing Isolated IgG4-associated Sclerosing Cholangitis

Journal of Digestive Endoscopy, 2019
The most common causes of recurrent cholangitis are biliary stones and neoplasia. Primary types of sclerosing cholangitis such as IgG4-associated sclerosing cholangitis (IgG4-SC) and primary sclerosing cholangitis (PSC) are rare causes of recurrent ...
Gábor Zsóri, Dóra Illés, László Tiszlavicz, László Czakó   +3 more
doaj   +1 more source